NCT03910114View on ClinicalTrials.gov

Gadolinium-Based-Contrast-Agents (GBCA) Enhancement During MR Urography

CompletedOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

July 1, 1990

Primary Completion Date

April 1, 2019

Study Completion Date

April 1, 2019

Conditions
Magnetic Resonance Imaging Contrast Agents
Interventions
DRUG

Magnevist

GBCA enhancement

DRUG

Dotarem

GBCA enhancement

DRUG

Gadovist

GBCA enhancement

Trial Locations (2)

37232

Vanderbilt Childeen's Hospital, Nashville

Unknown

Children's Hospital of Philadelphia, Philadelphia

Sponsors

Collaborators (1)

Guerbet
All Listed Sponsors
collaborator

Guerbet

INDUSTRY

collaborator

Children's Hospital of Philadelphia

OTHER

lead

Vanderbilt University Medical Center

OTHER